FADD

From WikiMD's WELLNESSPEDIA

Extrinsic_apoptosis.jpg

FADD (Fas-Associated protein with Death Domain) is a crucial adaptor molecule involved in the process of apoptosis, or programmed cell death. It plays a significant role in the extrinsic pathway of apoptosis, which is initiated by the binding of death ligands to their corresponding death receptors on the cell surface.

Structure[edit]

FADD is composed of two main domains: the death domain (DD) and the death effector domain (DED). The death domain is responsible for interactions with the death domains of other proteins, such as the Fas receptor (also known as CD95) and TNF receptor 1. The death effector domain facilitates the recruitment of downstream signaling molecules, such as procaspase-8.

Function[edit]

FADD is primarily involved in the formation of the Death-Inducing Signaling Complex (DISC). Upon the binding of a death ligand, such as Fas ligand (FasL) or TNF-related apoptosis-inducing ligand (TRAIL), to their respective death receptors, FADD is recruited to the receptor complex through its death domain. This recruitment allows FADD to interact with procaspase-8 via its death effector domain, leading to the activation of caspase-8. Activated caspase-8 then initiates a cascade of downstream caspase activations, ultimately resulting in apoptosis.

Role in Disease[edit]

Dysregulation of FADD-mediated signaling pathways can lead to various diseases. Overactivation of FADD can result in excessive cell death, contributing to conditions such as neurodegenerative diseases and ischemic injury. Conversely, insufficient FADD activity can lead to the survival of abnormal cells, contributing to the development of cancer and autoimmune diseases.

Research and Therapeutic Potential[edit]

FADD is a target of interest in the development of therapeutic interventions for diseases characterized by abnormal apoptosis. Modulating FADD activity or its interactions with other proteins in the apoptotic pathway holds potential for the treatment of cancer, autoimmune diseases, and neurodegenerative disorders.

See also[edit]

References[edit]


External links[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss blog | Philadelphia weight loss blog | Sleep medicine and sleep apnea services | W8MD MedSpa and wellness | Weight loss prescriptions

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.